title: Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitization by heat and MDL 72527.
abstract: In situ formation of cytotoxic metabolites by an enzyme-catalyzed reaction is a recent approach in cancer chemotherapy. We demonstrate that multidrug resistant human melanoma cells (M14 ADR) are more sensitive than the corresponding wild type cells (M14 WT) to hydrogen peroxide and aldehydes, the products of bovine serum amine oxidase (BSAO)-catalyzed oxidation of spermine. Hydrogen peroxide was mainly responsible for the loss of cell viability. With about 20%, the aldehydes formed from spermine contribute also to cytotoxicity. Elevation of temperature from 37 degrees C to 42 degrees C decreased survival of both cell lines by about one log unit. Pre-treatment with N1,N4-bis(2,3-butadienyl)-1,4-butanediamine (MDL 72527), a lysosomotropic compound, sensitized cells to toxic spermine metabolites. MDL 72527 (at 300 microM) produced in M14 cells numerous cytoplasmic vacuoles which, however, disappeared by 24 h, even in the presence of the drug. Mitochondrial damage, as observed by transmission electron microscopy, correlated better with the cytotoxic effects of the treatment than vacuole formation. Since the release of lysosomal enzymes causes oxidative stress and apoptosis, we suggest that the lysosomotropic effect of MDL 72527 is the major reason for its sensitizing effect.
authors.affiliation: Department of Biochemical Sciences A. Rossi Fanelli, University of Rome La Sapienza and CNR, Biology and Molecular Pathology Institutes, Piazzale Aldo Moro 5, 00185 Rome, Italy. enzo.agostinelli@uniromal.it
authors.forename: Enzo
authors.initials: E
authors.lastname: Agostinelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Belli
authors.forename: Agnese
authors.initials: A
authors.lastname: Molinari
authors.forename: Maria
authors.initials: M
authors.lastname: Condello
authors.forename: Paola
authors.initials: P
authors.lastname: Palmigiani
authors.forename: Laura Dalla
authors.initials: LD
authors.lastname: Vedova
authors.forename: Manuela
authors.initials: M
authors.lastname: Marra
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Seiler
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Arancia
mesh_terms: D000818:Animals; D017304:Annexin A5 / Q000378:metabolism; D016466:CHO Cells; D045744:Cell Line, Tumor; D002470:Cell Survival; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005434:Flow Cytometry; D006358:Hot Temperature; D006801:Humans; D008545:Melanoma / Q000201:enzymology* / Q000378:metabolism; D008854:Microscopy, Electron; D015394:Molecular Structure; D008995:Monoamine Oxidase / Q000494:pharmacology; D010084:Oxidation-Reduction; D011700:Putrescine / Q000031:analogs & derivatives* / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000378:metabolism; D013096:Spermine / Q000378:metabolism* / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D017304:Annexin A5; D017382:Reactive Oxygen Species; C044445:MDL 72527; D013096:Spermine; D004317:Doxorubicin; D008995:Monoamine Oxidase; D011700:Putrescine